ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 223,34
0,05%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Emergent Biosolutions Inc (EBS)

  7. Emergent Biosolutions Inc (EBS) Actualités

EBS Emergent Biosolutions Inc

6,13
0,09 (1,49%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Emergent Biosolutions Inc EBS NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,09 1,49% 6,13 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,01 5,75 6,2756 6,17 6,04
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202415:02GLOBEEmergent BioSolutions Continues Driving Progress Against the..
04/6/202422:19EDGAR2Form 144 - Report of proposed sale of securities
31/5/202421:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202413:34EDGAR2Form 8-K - Current report
29/5/202403:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202413:17GLOBEEmergent BioSolutions to Hold Virtual Annual Meeting of..
01/5/202422:57GLOBEEmergent BioSolutions Reports First Quarter 2024 Financial..
01/5/202422:10GLOBEEmergent BioSolutions Announces Strategic Operational..
01/5/202417:03GLOBEEmergent BioSolutions Releases New Survey Findings..
30/4/202423:26GLOBEEmergent BioSolutions Announces Amendment to its Existing..
22/4/202414:05GLOBEEmergent BioSolutions to Release First Quarter 2024..
01/4/202414:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
28/3/202413:15GLOBEEmergent BioSolutions Continues to Broaden Access, Awareness..
25/3/202413:05GLOBEEmergent BioSolutions Receives NAI Status for Baltimore..
08/3/202422:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202402:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:31GLOBEEmergent BioSolutions Reports Fourth Quarter 2023 Financial..
06/3/202422:15EDGAR2Form 8-K - Current report
06/3/202412:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
05/3/202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:00GLOBEEmergent BioSolutions to Release Fourth Quarter & Full Year..
28/2/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202402:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202413:25EDGAR2Form 8-K - Current report
21/2/202413:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
11/1/202413:41EDGAR2Form 8-K - Current report
09/1/202414:40EDGAR2Form 8-K - Current report
09/1/202413:30GLOBEEmergent BioSolutions to Present at the 42nd Annual J.P...
27/12/202312:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
11/12/202323:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/12/202313:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/11/202313:15EDGAR2Form 8-K - Current report
28/11/202312:59GLOBEEmergent BioSolutions Receives $75 Million Contract Option..
24/11/202313:30GLOBEEmergent BioSolutions Receives NYSE Notice Regarding Delayed..
24/11/202313:17EDGAR2Form 8-K - Current report
16/11/202322:11EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NYSE
EBS
Emergent Biosolutions
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés